By August 18th, Chinese drug abuse prevention association, sponsored by the British reckitts Pharmaceutical Co. Ltd., with the national development and Reform Commission, the state UNODC "Ministry of public security, Ministry of justice, Ministry of health and other departments, the provinces, city, district health industry leaders and experts to participate in the" 2012 "Shu Beisheng" the first Beijing International Symposium held at the Beijing Convention Center.
The meeting, by China and America, British drug experts on multi drug treatment, methadone maintenance treatment, the drug control AIDS epidemic population the latest progress and challenges, the treatment of a variety of opioid dependence, China's drug abuse epidemic situation and prevention policies and measures, development and efficacy of outpatient treatment of opioid the obstacles and "Shu Beisheng" drugs to carry out academic exchanges.
By the British reckitts pharmaceutical limited company research and development of "Shu Beisheng" 2 mg and 6 mg tablets / film agent is dissolved under the tongue, its main ingredient is buprenorphine and naloxone compound, its effectiveness is: two kinds of drug treatment efficacy as one solution, play a more effective role in drug due to dissolve under the tongue; can carry; to prevent abuse, if drug addicts will dissolve tablets for injection, will produce unpleasant withdrawal symptoms; reduce the drug level. At present, "Shu Beisheng" has been in Yunnan drug dependence research institute, Xinjiang, Guangxi and other places to carry out clinical trials, will soon be China entered the market.
A new drug is about to enter the "Shu Beisheng - China"
2012 - the first Beijing International Symposium on "Shu Beisheng"
By August 18th, Chinese drug abuse prevention association, sponsored by the British reckitts Pharmaceutical Co. Ltd., with the national development and Reform Commission, the state UNODC "Ministry of public security, Ministry of justice, Ministry of health and other departments, the provinces, city, district health industry leaders and experts to participate in the" 2012 "Shu Beisheng" the first Beijing International Symposium held at the Beijing Convention Center.
The meeting, by China and America, British drug experts on multi drug treatment, methadone maintenance treatment, the drug control AIDS epidemic population the latest progress and challenges, the treatment of a variety of opioid dependence, China's drug abuse epidemic situation and prevention policies and measures, development and efficacy of outpatient treatment of opioid the obstacles and "Shu Beisheng" drugs to carry out academic exchanges.
By the British reckitts pharmaceutical limited company research and development of "Shu Beisheng" 2 mg and 6 mg tablets / film agent is dissolved under the tongue, its main ingredient is buprenorphine and naloxone compound, its effectiveness is: two kinds of drug treatment efficacy as one solution, play a more effective role in drug due to dissolve under the tongue; can carry; to prevent abuse, if drug addicts will dissolve tablets for injection, will produce unpleasant withdrawal symptoms; reduce the drug level. At present, "Shu Beisheng" has been in Yunnan drug dependence research institute, Xinjiang, Guangxi and other places to carry out clinical trials, will soon be China entered the market.
